IINN - מכפיל PEG Inspira Technologies Oxy

Inspira Technologies Oxy develops blood oxygen molecular saturation systems, ensuring high margins through its patents. An R&D breakthrough in ART devices is transforming resuscitation standards. The PEG fundamental indicator captures this trend, with the value holding at 0.00, confirming the potential for undervaluation. Compact oxygenation solutions also contribute to achieving ESG goals in medicine.

The uniqueness of Inspira Technologies Oxy respiratory support systems creates a steady stream of service revenue through the sale of consumables. The P/E ratio relative to earnings growth rates allows for an assessment of the cost of this growth. This coefficient determines the fairness of the market premium for future business expansion. GURU.Markets analysts utilize the PEG undervaluation factor to identify hidden potential, where values below one signal that the asset is undervalued.